Viewing Study NCT05448820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-04-21 @ 12:37 PM
Study NCT ID: NCT05448820
Status: UNKNOWN
Last Update Posted: 2023-09-21
First Post: 2022-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Sponsor: Tracon Pharmaceuticals Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Sarcoma View
None Metastatic Sarcoma View
None Soft Tissue Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tracon View
None STS View
None LMS View
None DDLS View
None ASPS View
None envafolimab View
None YH001 View
None CTLA-4 View
None PD-L1 View
None chondrosarcoma View